European Quality of Care Pathways Study on the Effect of Care Pathways on Interprofessional Teamwork (EQCP-TEAM)

NCT01435538 | Completed DMC

• 1 other identifier: EPA-EQCP-003
• Study Type: interventional
• Target: 984
• Locations: 1 country
• Sites: 1

Brief Summary

Care pathways are complex interventions to support the interprofessional team in the redesign of their care process. This international cluster randomised trial will analyse the impact of the development and implementation of care pathways on the interprofessional teamwork.

Conditions

Chronic Obstructive Pulmonary Disease; Proximal Femur Fracture

Keywords

interprofessional teamwork; care pathways; team communication; team coordination; Chronic Obstructive Pulmonary Disease Teams; Proximal Femur Fracture Teams

Outcome Measures

Primary Outcomes (1)

• Relational Coordination

  Relational coordination describes the quality of communication and functional relations within a interprofessional team with shared goals and interdependent tasks.

  For average period of 3 months

Secondary Outcomes (3)

• Perceived Organisation of Care

  For average period of 3 months

• Work engagement

  For average period of 3 months

• Team Climate

  For average period of 3 months

Study Arms (2)

Care pathway teams.

EXPERIMENTAL

In this experimental arm, the interprofessional teams will develop and implement a care pathways.

Behavioral: Care pathway.

Usual care teams.

NO INTERVENTION

In the no intervention arm, the interprofessional teams will deliver usual care without implementing the intervention.

Interventions

Care pathway. BEHAVIORAL

The intervention group will implement a care pathway for PFF or COPD containing three active components: a formative evaluation of the actual teams' performance, a set of evidence based key interventions and a training in pathway-development.

Care pathway teams.

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Next to this, they have to agree that they will not develop and implement a care pathway for COPD- exacerbation of PFF within the time frame of the study when randomized in the control group
• Finally, the participating hospitals need an expected volume of more than one hundred COPD-exacerbation or PFF patients annually.
• All professionals that according to the medical head of the division and head nurse are member of the interprofessional team caring for COPD-exacerbation or PFF patients from admission until discharge out of the acute hospital ward
• To be part of the interprofessional care team is further conceptualized as being part of the group of clinicians and staff who have a shared clinical purpose and direct care responsibilities for the respective patient group during the set time period
• All individual participants need to be member of the team during one specific week, where patients are being followed for the two other trials of the EQCP-project (8). This specific week is chosen by the study coordinator and can be defined as an average week, with normal staff ratios
• Because we want to study interprofessional teamwork, each cluster is asked to minimally include the orthopedic surgeons/pneumologists, head nurse, nurses, physiotherapists and social workers in their sample. Based on their own judgment, the chief medical doctor, in consensus with the head nurse, can decide to include other professional groups in their sample
• In some hospitals COPD-exacerbation or PFF patients are being admitted at multiple nursing wards, e.g. due to capacity problems or other organizational issues. If that is the case, then the clusters are asked to only include these team members that are working on the ward where the respective patient groups are being admitted most frequently.

You may not qualify if:

• All team members that are not working (e.g. on leave) during the chosen week
• All team members who are only temporarily part of the team (e.g. student nurses in training).

Sponsors & Collaborators

• Dr. Kris Vanhaecht: lead
• KU Leuven: collaborator
• University of Eastern Piedmont: collaborator

Study Sites (1)

Katholieke Universiteit Leuven

Leuven, 3000, Belgium

Location

Related Publications (3)

• Deneckere S, Robyns N, Vanhaecht K, Euwema M, Panella M, Lodewijckx C, Leigheb F, Sermeus W; EQCP-studygroup. Indicators for follow-up of multidisciplinary teamwork in care processes: results of an international expert panel. Eval Health Prof. 2011 Sep;34(3):258-77. doi: 10.1177/0163278710393736. Epub 2010 Dec 29.

  PMID: 21190951 BACKGROUND

• Handoll HH, Cameron ID, Mak JC, Panagoda CE, Finnegan TP. Multidisciplinary rehabilitation for older people with hip fractures. Cochrane Database Syst Rev. 2021 Nov 12;11(11):CD007125. doi: 10.1002/14651858.CD007125.pub3.

  PMID: 34766330 DERIVED

• Deneckere S, Euwema M, Lodewijckx C, Panella M, Sermeus W, Vanhaecht K. The European quality of care pathways (EQCP) study on the impact of care pathways on interprofessional teamwork in an acute hospital setting: study protocol: for a cluster randomised controlled trial and evaluation of implementation processes. Implement Sci. 2012 May 18;7:47. doi: 10.1186/1748-5908-7-47.

  PMID: 22607698 DERIVED

Related Links

• European Pathway Association

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive; Proximal Femoral Fractures

Interventions

Critical Pathways

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Femoral Neck Fractures; Hip Fractures; Femoral Fractures; Fractures, Bone; Wounds and Injuries; Hip Injuries; Leg Injuries

Intervention Hierarchy (Ancestors)

Patient Care Planning; Comprehensive Health Care; Patient Care Management; Health Services Administration

Study Officials

• Kris Vanhaecht, PhD

  KU Leuven

  STUDY DIRECTOR

• Walter Sermeus, PhD

  KU Leuven

  PRINCIPAL INVESTIGATOR

• Massimiliano Panella, PhD

  Amedeo Avogadro University of Eastern Piemont

  PRINCIPAL INVESTIGATOR

• Svin Deneckere, MSc

  KU Leuven

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Secretary General

Study Record Dates

• First Submitted: September 15, 2011
• First Posted: September 16, 2011
• Study Start: May 1, 2009
• Primary Completion: June 1, 2014
• Study Completion: January 1, 2017
• Last Updated: October 13, 2017

Record last verified: 2017-10

Locations

BE (1)